- Home
- VFL vs LNSR Comparison
VFL vs LNSR Comparison
Compare VFL & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VFL | LNSR |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.7M | 142.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VFL | LNSR |
|---|---|---|
| Price | $10.19 | $11.50 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 38.0K | ★ 51.3K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 4.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,141,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.02 |
| 52 Week Low | $7.93 | $7.13 |
| 52 Week High | $10.77 | $17.31 |
Technical Indicators
Market Signals| Indicator | VFL | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 59.73 |
| Support Level | $10.08 | $11.00 |
| Resistance Level | $10.26 | $11.63 |
| Average True Range (ATR) | 0.08 | 0.41 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 66.67 | 89.58 |
Price Performance
Historical ComparisonAbout VFL abrdn National Municipal Income Fund
abrdn National Municipal Income Fund is a closed-end investment fund. The Fund's investment objective is to seek to provide current income exempt from regular federal income tax, consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.